Bulevirtide (Hepcludex; Gilead Sciences, Inc.) is the first FDA-approved treatment for chronic hepatitis delta virus infection.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-bulevirtide-hepatitis-delta-virus-2026a1000h3x?src=rss
Author :
Publish date : 2026-05-26 06:16:00
Copyright for syndicated content belongs to the linked Source.